Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    9742977 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting HbA1c Variability in Type II Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Metformin;   Drug: Gliclazide;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Pioglitazone;   Drug: Dapagliflozin;   Drug: human insulin
2 Recruiting ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Saxagliptin;   Drug: Dapagliflozin;   Drug: Placebo
3 Recruiting Financial Incentives and Text Messaging to Improve African American Womens' Glycemic Control
Condition: Diabetes Mellitus
Intervention: Behavioral: IM/SMS + Incentive Condition
4 Unknown  Efficacy Study of Metformin Glycinate on Postprandial Lipemia
Condition: Type 2 Diabetes
Interventions: Drug: Metformin glycinate;   Drug: Metformin Hydrochloride
5 Unknown  Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Metformin glycinate;   Drug: Metformin hydrochloride
6 Completed The Effects of Metformin on Blood Vessel Structure and Function
Conditions: Obesity;   Hypertension;   Hypercholesterolemia;   Hyperglycemia
Interventions: Drug: Metformin;   Drug: Placebo

Indicates status has not been verified in more than two years